BroadOak Logo

Latest News

Updates on BroadOak investments, transactions, events, and industry news.

BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services.  ZoBio is

BroadOak Capital Partners led Pluristyx’s latest fundraising round, which featured participation from existing investors and key

BroadOak Capital Partners advised Biosynth on the acquisition of celares GmbH.  Celares provides customized bioconjugation solutions

Genomenon, a BroadOak portfolio company and a leader in genomic intelligence, acquired Boston Genetics, a genomics

BroadOak Capital Partners invested in Indee Labs out of its BioTools Venture Fund to support the

Sanguine is a leader in custom specimen procurement used by biopharmaceutical companies to accelerate precision medicine

BroadOak invested in CDI Labs, a provider of serological biomarker discovery services and monoclonal antibody manufacturing

PBS Biotech Raises $22M

BroadOak portfolio company PBS Biotech, an innovative manufacturer of single-use bioreactors, has completed a $22 million

BroadOak portfolio company PhenoVista Biosciences, a leading provider of both custom and off-the-shelf imaging-based assay services,

It is an exciting time at BroadOak as we help advance innovative life sciences technologies.

Holly Atallah
Director of Finance & Operations

BroadOak Logo Only

Our Story

BroadOak has advised and invested in life sciences companies for over 15 years. Get to know us.